In this study, we did not assess other mechanisms that probably contribute to the efficacy of combined quercetin-docetaxel treatment on MDA-MB-231 BC cell line such as NF-κB, caspases activation, BCL-xL, p38 MAPK, p27, p21, and also autophagic pathways. The gene discussed is BCL2L1; the disease is breast cancer.